Boston Scientific Corp (BSX)

Industry Medical Devices

This stock can be held in an Investment ISA and an Investment Account
Sell

$105.00

Buy

$106.20

arrow-up$1.18 (+1.13%)

Boston Scientific Corp is a developer, manufacturer, and marketer of medical devices. The firm markets its devices to health-care professionals and institutions globally. Foreign sales account for nearly half of the firm's total sales.
Prices updated at 17 May 2025, 00:52 EDT
| Prices minimum 15 mins delay
|
Prices in USD
Sector
Healthcare
Industry
Medical Devices
Chairman
Mr. Michael F. Mahoney
CEO
Mr. Michael F. Mahoney
Most recent earnings
31 Dec 2024
Fiscal year end
31 Dec 2024
Employees
53,000
Head office
300 Boston Scientific Way
Marlborough
United States
01752-1234
mobile
+1 508 683-4000
letter
BSXInvestorRelations@bsci.com

Key personnel

Owner nameSalaryBonusAll other compensationTotal compensationRestricted stock award
Mr. Daniel J. Brennan
Executive Vice President and Chief Financial Officer
0.84m--6.69m-
Mr. Jonathan R. Monson
Senior Vice President, Investor Relations
-----
Mr. David C. Habiger
Independent Director
-----
Mr. Edward J. Ludwig
Lead Independent Director
0.16m--0.38m-
Mr. David S. Wichmann
Independent Director
0.15m--0.36m-
Ms. Ellen M. Zane
Independent Director
0.14m--0.36m-
Mr. Yoshiaki Fujimori
Independent Director
0.14m--0.35m-
Senator John E. Sununu
Independent Director
0.14m--0.36m-
Mr. Joseph M. Fitzgerald
Executive Vice President and Group President, Cardiology
0.84m--6.34m-
Mr. Michael F. Mahoney
Chairman of the Board, President and Chief Executive Officer
1.40m--21.42m-
Mr. Vance R. Brown
Senior Vice President, General Counsel, Corporate Secretary
-----
Mr. Jeffrey B. Mirviss
Executive Vice President and President, Peripheral Interventions
0.68m--4.03m-
Dr. Cheryl B. Pegus, M.D.
Independent Director
0.08m--0.29m-
Mr. John Bradley Sorenson
Executive Vice President, Global Operations
-----
Mr. Arthur C. Butcher
Executive Vice President and Group President, MedSurg and Asia Pacific
0.71m--5.01m-
Dr. Jessica L. Mega, M.D.,M.P.H.
Independent Director
0.12m--0.34m-
Ms. Susan E. Morano
Independent Director
0.12m--0.34m-
Ms. Miriam O’Sullivan
Senior Vice President and Chief Human Resources Officer
-----

Top 5 shareholders

Owner nameNo. of sharesShare as % of port.Last changePortfolio % changeDate of portfolio% Total assets
BlackRock Inc141,671,0660.3001826446281.90224830 Apr 20259.58
Vanguard Group Inc134,588,7290.2454716979451.277730 Apr 20259.10
FMR Inc128,597,2140.82825-3845669-2.90364330 Apr 20258.69
Fidelity Management and Research Company128,597,2140.82825-3845669-2.90364330 Apr 20258.69
Fidelity Management & Research Company LLC102,762,36198.96766-1611936-30 Apr 20256.95

Director dealings

DateActionNamePriceValueNo. of sharesHolding (%)Additional info
03 Dec 2024-Mr. Joseph M. Fitzgerald90.294,515148,168--
11 Feb 2025-Mr. Joseph M. Fitzgerald105.981,531,093172,863--
11 Feb 2025-Mr. Joseph M. Fitzgerald--187,310--
10 Dec 2024-Mr. Joseph M. Fitzgerald89.971,799148,148--
02 Dec 2024-Ms. Wendy Carruthers17.2652,91935,094--
02 Dec 2024-Ms. Wendy Carruthers--13,183--
02 Dec 2024-Ms. Wendy Carruthers-----
02 Dec 2024-Ms. Wendy Carruthers90.78633,91729,308--
02 Dec 2024-Ms. Wendy Carruthers24.5529,38636,291--
27 Nov 2024-Ms. Emily Woodworth90.65121,1052,957--
26 Nov 2024-Mr. Michael F. Mahoney--201,478--
26 Nov 2024-Mr. Joseph M. Fitzgerald--148,118--
25 Nov 2024-Mr. Joseph M. Fitzgerald--159,354--
25 Nov 2024-Mr. Arthur C. Butcher17.2617,41514,988--
25 Nov 2024-Mr. Arthur C. Butcher--12,706--
25 Nov 2024-Mr. Arthur C. Butcher--4,036--
25 Nov 2024-Mr. Arthur C. Butcher89.271,250,664978--
25 Nov 2024-Mr. Arthur C. Butcher22.7172,15013,979--
21 Nov 2024-Mr. Edward J. Ludwig91.63446,90239,398--
12 Nov 2024-Mr. John Bradley Sorenson--37,096--
Please note that past performance is not a reliable indicator of future returns.


Important Information

Please note the value of investments can go down as well as up so you may get back less than you invested. This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to an authorised financial adviser. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and(3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
© Copyright 2025 Morningstar. All rights reserved.